# Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication

> **NCT07746934** · NA · NOT_YET_RECRUITING · sponsor: **University of Medicine and Pharmacy at Ho Chi Minh City** · enrollment: 600 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Metronidazole
- **DRUG:** Tinidazole 500mg
- **DRUG:** tetracyline
- **DRUG:** Bismuth Subcitrate
- **DRUG:** esomeprazole 40 mg

## Key facts

- **NCT ID:** NCT07746934
- **Lead sponsor:** University of Medicine and Pharmacy at Ho Chi Minh City
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-27
- **Primary completion:** 2027-08-27
- **Final completion:** 2027-12-27
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746934, "Metronidazole- Versus Tinidazole-Based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*